| Trial Identifier: | ACE-LY-002 |
| Sponsor: | AcertaPharma |
| NCTID:: | NCT02112526 |
| Start Date: | August 2014 |
| Primary Completion Date: | June 2020 |
| Study Completion Date: | December 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| English Translation |
| Country | Location |
|---|---|
| GB | Leicester, GB, LE1 7RH |
| GB | Plymouth, GB, PL6 8DH |
| US, OH | Columbus, OH, US, 43210 |
| US, CA | Los Angeles, CA, US, 90095 |
| US, GA | Atlanta, GA, US, 30322 |
| US, NY | New York, NY, US, 10021 |
| US, TX | Houston, TX, US, 77030 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company